Shuttle Pharmaceuticals Holdings, Inc. SHPH
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 99.73% | -14.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 78.16% | -20.49% | |||
| Operating Income | -78.16% | 20.49% | |||
| Income Before Tax | -46.13% | 17.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -46.13% | 17.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.13% | 17.68% | |||
| EBIT | -78.16% | 20.49% | |||
| EBITDA | -21.12% | 11.34% | |||
| EPS Basic | 27.57% | 54.69% | |||
| Normalized Basic EPS | 10.18% | 59.93% | |||
| EPS Diluted | 27.57% | 54.79% | |||
| Normalized Diluted EPS | 10.18% | 59.93% | |||
| Average Basic Shares Outstanding | 101.75% | 81.66% | |||
| Average Diluted Shares Outstanding | 101.75% | 81.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||